A phase II trial of the Src kinase inhibitor AZD0530 in patients with metastatic or locally advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma: A trial of the PMH phase II consortium

被引：0

作者：

Mackay, H.

Au, H.

McWhirter, E.

Alcindor, T.

Jarvi, A.

MacAlpine, K.

Wang, L.

Wright, J. J.

Oza, A. M.

机构：

[1] Princess Margaret Hosp, Univ Hlth Network, Toronto, ON M4X 1K9, Canada

[2] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada

[3] Juravinski Canc Ctr, Hamilton, ON, Canada

[4] McGill Univ, Ctr Hlth, Montreal, PQ, Canada

[5] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada

[6] NCI, Canc Therapy Evaluat Program, Bethesda, MD 20892 USA

来源：

关键词：

D O I：

10.1200/jco.2010.28.15_suppl.e14544

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e14544

引用

页数：1